Age-Related Hypercholesterolemia and HMG-CoA Reductase Dysregulation: Sex Does Matter (A Gender Perspective)

Although cardiovascular diseases are less prevalent in premenopausal women than in men, their occurrence in women increases at the onset of menopause, and the loss of female sex hormones contributes to the striking increase in cardiovascular morbidity and mortality in postmenopausal women. We present here a description of age-related disruption of lipid homeostasis, which particularly affects 3-hydroxy 3-methylglutaryl Coenzyme A reductase, the key rate-limiting enzyme in the cholesterol biosynthetic pathway. We further discuss the age- and gender-related dysregulation of this enzyme, providing new evidence for the different mechanisms driving dyslipidemia in elderly men and women. In addition, we introduce pharmacological methods of regulating HMGR and maintaining cholesterol homeostasis.

[1]  W. Kannel,et al.  Cardiovascular risk factors in the elderly , 1997, Coronary artery disease.

[2]  M. Sugano,et al.  Age-related changes in lipid metabolism in rats: the consequence of moderate food restriction. , 1988, Biochimica et biophysica acta.

[3]  M. Brown,et al.  A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[4]  D. Hardie,et al.  AMP‐activated protein kinase – development of the energy sensor concept , 2006, The Journal of physiology.

[5]  J. Goldstein,et al.  Erratum: Cholesterol feedback: From Schoenheimer's bottle to Scap's MELADL (Journal of Lipid Research (2009) 50 (S15-S27)) , 2009 .

[6]  S. Goldfarb,et al.  Evidence that physiologic levels of circulating estrogens and neonatal sex-imprinting modify postpubertal hepatic microsomal 3-hydroxy-3-methylglutaryl coenzyme A reductase activity. , 1980, Biochimica et biophysica acta.

[7]  J. Goldstein,et al.  Regulation of the mevalonate pathway , 1990, Nature.

[8]  Y. Murata,et al.  The aromatase knockout mouse presents with a sexually dimorphic disruption to cholesterol homeostasis. , 2003, Endocrinology.

[9]  Edward J. Masoro,et al.  Overview of caloric restriction and ageing , 2005, Mechanisms of Ageing and Development.

[10]  V. Pallottini,et al.  Modified HMG‐CoA reductase and LDLr regulation is deeply involved in age‐related hypercholesterolemia , 2006, Journal of cellular biochemistry.

[11]  G. Ness,et al.  Feedback and Hormonal Regulation of Hepatic 3-Hydroxy-3-Methylglutaryl Coenzyme a Reductase: The Concept of Cholesterol Buffering Capacity (44508) , 2000 .

[12]  L. Kuller,et al.  Lipoprotein Lipids in Older People: Results From the Cardiovascular Health Study , 1992, Circulation.

[13]  H. Brewer,et al.  Phosphorylation of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase and modulation of its enzymic activity by calcium-activated and phospholipid-dependent protein kinase. , 1985, The Journal of biological chemistry.

[14]  S. Incerpi,et al.  3-Hydroxy-3-methylglutaryl coenzyme A reductase deregulation and age-related hypercholesterolemia: A new role for ROS , 2005, Mechanisms of Ageing and Development.

[15]  M. Degawa,et al.  Gender‐related difference in altered gene expression of a sterol regulatory element binding protein, SREBP‐2, by lead nitrate in rats: Correlation with development of hypercholesterolemia , 2006, Journal of applied toxicology : JAT.

[16]  Yan Wang,et al.  A proprotein convertase subtilisin/kexin type 9 neutralizing antibody reduces serum cholesterol in mice and nonhuman primates , 2009, Proceedings of the National Academy of Sciences.

[17]  Joseph L. Goldstein,et al.  Protein Sensors for Membrane Sterols , 2006, Cell.

[18]  V. Pallottini,et al.  Caloric restrictions affect some factors involved in age‐related hypercholesterolemia , 2007, Journal of cellular biochemistry.

[19]  B. Angelin,et al.  Pituitary control of cholesterol metabolism in normal and LDL receptor knock-out mice: effects of hypophysectomy and growth hormone treatment. , 2005, Biochimica et biophysica acta.

[20]  F. Russo,et al.  Estrogenic regulation of cholesterol biosynthesis and cell growth in DLD-1 human colon cancer cells , 2005, Scandinavian journal of gastroenterology.

[21]  B. Littenberg,et al.  Costs and health consequences of cholesterol screening for asymptomatic older Americans. , 1991, Archives of internal medicine.

[22]  E. Stadtman Protein oxidation and aging , 2006, Science.

[23]  B. Angelin,et al.  Growth hormone and bile acid synthesis. Key role for the activity of hepatic microsomal cholesterol 7alpha-hydroxylase in the rat. , 1997, The Journal of clinical investigation.

[24]  Peter J Espenshade,et al.  Regulation of sterol synthesis in eukaryotes. , 2007, Annual review of genetics.

[25]  J. Goldstein,et al.  The SREBP Pathway: Regulation of Cholesterol Metabolism by Proteolysis of a Membrane-Bound Transcription Factor , 1997, Cell.

[26]  D. Harman Aging: a theory based on free radical and radiation chemistry. , 1956, Journal of gerontology.

[27]  W. Frishman,et al.  Pharmacologic Inhibition of Squalene Synthase and Other Downstream Enzymes of the Cholesterol Synthesis Pathway: A New Therapeutic Approach to Treatment of Hypercholesterolemia , 2009, Cardiology in review.

[28]  N. Baquer,et al.  Administration of estradiol and progesterone modulate the activities of antioxidant enzyme and aminotransferases in naturally menopausal rats , 2005, Experimental Gerontology.

[29]  D. Harats,et al.  The Ubiquitin-Proteasome Pathway Mediates the Regulated Degradation of Mammalian 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase* , 2000, The Journal of Biological Chemistry.

[30]  Jonathan C. Cohen,et al.  Dual roles for cholesterol in mammalian cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[31]  W. Castelli,et al.  Epidemiology of coronary heart disease: the Framingham study. , 1984, The American journal of medicine.

[32]  Natalie W. Paul,et al.  Birth defects, original article series , 1982 .

[33]  S. Hawley,et al.  Characterization of the AMP-activated Protein Kinase Kinase from Rat Liver and Identification of Threonine 172 as the Major Site at Which It Phosphorylates AMP-activated Protein Kinase* , 1996, The Journal of Biological Chemistry.

[34]  R. V. Omkumar,et al.  Modulation of Syrian hamster 3-hydroxy-3-methylglutaryl-CoA reductase activity by phosphorylation. Role of serine 871. , 1994, The Journal of biological chemistry.

[35]  V. Pallottini,et al.  Rat HMGCoA reductase activation in thioacetamide-induced liver injury is related to an increased reactive oxygen species content. , 2006, Journal of hepatology.

[36]  V. Pallottini,et al.  Mechanisms underlying the impaired regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in aged rat liver , 2004, Mechanisms of Ageing and Development.

[37]  D. Hardie,et al.  Age-related HMG-CoA reductase deregulation depends on ROS-induced p38 activation , 2007, Mechanisms of Ageing and Development.

[38]  V. Pallottini,et al.  Cholesterol: from feeding to gene regulation , 2007, Genes & Nutrition.

[39]  V. Janssens,et al.  Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. , 2001, The Biochemical journal.

[40]  G. Ness,et al.  Feedback and hormonal regulation of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase: the concept of cholesterol buffering capacity. , 2000, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[41]  V. Pallottini,et al.  Sex differences in hepatic regulation of cholesterol homeostasis. , 2008, The Journal of endocrinology.

[42]  S. M. Cowsik,et al.  Estradiol and progesterone treatments change the lipid profile in naturally menopausal rats from different age groups , 2004, Biogerontology.

[43]  S. Maxwell Women and heart disease , 1998, Basic Research in Cardiology.

[44]  V. Pallottini,et al.  Stimulation of autophagy by antilipolytic drugs may rescue rodents from age-associated hypercholesterolemia. , 2009, Rejuvenation research.

[45]  Joseph L Goldstein,et al.  Insig-dependent Ubiquitination and Degradation of Mammalian 3-Hydroxy-3-methylglutaryl-CoA Reductase Stimulated by Sterols and Geranylgeraniol* , 2003, Journal of Biological Chemistry.

[46]  Joseph L Goldstein,et al.  SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. , 2002, The Journal of clinical investigation.

[47]  D. Reed,et al.  Is elevated serum cholesterol level a risk factor for coronary heart disease in the elderly? , 1990, JAMA.

[48]  G. Iwamoto,et al.  Increased adipose tissue in male and female estrogen receptor-α knockout mice , 2000 .

[49]  J. Sowers,et al.  Female sex hormones and cardiovascular disease in women , 1997 .

[50]  V. Pallottini,et al.  Hypercholesterolemia and 3-hydroxy-3-methylglutaryl coenzyme A reductase regulation in aged female rats , 2010, Experimental Gerontology.

[51]  E. Barrett-Connor,et al.  Ischemic heart disease risk factors after age 50. , 1984, Journal of chronic diseases.

[52]  M. Marino,et al.  Age-related changes of cholesterol and dolichol biosynthesis in rat liver , 2002, Mechanisms of Ageing and Development.

[53]  R. Dean,et al.  Protein oxidation and ageing , 2001, Experimental Gerontology.